MICHELLE RAMSBERGER: Open Payments
NPI 1417953753 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,222 in 107 payments from 16 companies in 2025. Trend: 2023 $1,521 · 2024 $1,767 · 2025 $2,222
Food & beverage: $2,042Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $661 |
| Galderma Laboratories, L.P. | 12 | $279 |
| ABBVIE INC. | 16 | $209 |
| UCB, Inc. | 8 | $202 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $149 |
| Regeneron Healthcare Solutions, Inc. | 6 | $140 |
| Amgen Inc. | 5 | $108 |
| Lilly USA, LLC | 5 | $86 |
| Botanix SB Inc | 3 | $79 |
| LEO Pharma Inc. | 3 | $75 |
Products named: TREMFYA, NEMLUVIO, Bimzelx, SKYRIZI, DUPIXENT, OTEZLA, TALTZ, SOFDRA.
Industry payments across PA — which companies pay providers there.
